about
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pa...
Read More738.6K XNAS Volume
XNAS 06 Jun, 2025 5:30 PM (EDT)
Board Meeting
The next board meeting for Alector Inc is on 12 Jun 2025 for the purpose of Alector Inc Annual General Meeting for 2025
See details
Low Financial Strength
Expensive Valuation
Technically Neutral
Momentum Trap
These stocks are the ones with poor quality and also financials and technical ranging from bad to medium score. This indicates that investors should be highly watchful with these stocks.
View Similar
Embed DVM
Alector Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..